Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number	Program Official
Alexandrov, Ludmil B	University Of California, San Diego United States	Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition	5U01CA290479-03	Wendy Wang, Ph.D., M.Sc.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	5U01CA282272-03	Matthew Young, Ph.D.
Zheng, Yingye	Fred Hutchinson Cancer Center United States	Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit	5U24CA288185-03	Guillermo Marquez, Ph.D.
Ghosh, Jayashri	Temple Univ Of The Commonwealth United States	Development of blood-based methylation biomarkers for CRC risk prediction	5R01CA281948-03	Matthew Young, Ph.D.
Elias, Kevin	Cleveland Clinic Lerner Com-Cwru United States	Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness	7R03CA283252-02	Christos Patriotis, Ph.D., M.Sc.
Villanueva, Augusto	Icahn School Of Medicine At Mount Sinai United States	Liquid biopsy and radiomics for liver cancer surveillance	4U01CA283931-03	Sidney Fu, M.D.
Zarrinpar, Amir	University Of California, San Diego United States	Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer	5U01CA265719-05	Guillermo Marquez, Ph.D.
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	5R21CA279916-02	Matthew Young, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-04	Matthew Young, Ph.D.
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-04	Sidney Fu, M.D.
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05	Nicholas Hodges, Ph.D.
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	5R21CA280445-02	Wendy Wang, Ph.D., M.Sc.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	5R01CA285980-02	Guillermo Marquez, Ph.D.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	5R21CA282380-02	Wendy Wang, Ph.D., M.Sc.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02	Wendy Wang, Ph.D., M.Sc.